Lung Imaging and Artificial Intelligence in ARDS.
Davide ChiumelloSilvia CoppolaGiulia CatozziFiammetta DanzoPierachille SantusDejan RadovanovicPublished in: Journal of clinical medicine (2024)
Artificial intelligence (AI) can make intelligent decisions in a manner akin to that of the human mind. AI has the potential to improve clinical workflow, diagnosis, and prognosis, especially in radiology. Acute respiratory distress syndrome (ARDS) is a very diverse illness that is characterized by interstitial opacities, mostly in the dependent areas, decreased lung aeration with alveolar collapse, and inflammatory lung edema resulting in elevated lung weight. As a result, lung imaging is a crucial tool for evaluating the mechanical and morphological traits of ARDS patients. Compared to traditional chest radiography, sensitivity and specificity of lung computed tomography (CT) and ultrasound are higher. The state of the art in the application of AI is summarized in this narrative review which focuses on CT and ultrasound techniques in patients with ARDS. A total of eighteen items were retrieved. The primary goals of using AI for lung imaging were to evaluate the risk of developing ARDS, the measurement of alveolar recruitment, potential alternative diagnoses, and outcome. While the physician must still be present to guarantee a high standard of examination, AI could help the clinical team provide the best care possible.
Keyphrases
- artificial intelligence
- acute respiratory distress syndrome
- machine learning
- extracorporeal membrane oxygenation
- big data
- mechanical ventilation
- computed tomography
- deep learning
- magnetic resonance imaging
- high resolution
- palliative care
- emergency department
- positron emission tomography
- endothelial cells
- end stage renal disease
- chronic kidney disease
- weight loss
- risk assessment
- human health
- weight gain
- body weight
- pluripotent stem cells